« Back to the previous page

Also available in:

Buyer for pre-clinical animal model pharmaceutical company in Europe

Company to buy

  • Size: mid-sized or large company
  • Revenue: 5-50 M EUR
  • Location of the target: Worldwide
  • #CFIE PHB034


Overview of pre-clinical animal model pharmaceutical company wanted

A pharmaceutical company would like to acquire a pharma company from pre-clinical pharmaceutical industry that has experiences with expertise in ancillary services for animal models and CROs simultaneously with manufacturing and B2B services. The desired revenue is from 5 to 50 million euro.

Profile (strategy) of this pre-clinical animal model pharmaceutical company buyer

The buyer is a US licensed company that operates as a large breeder and supplier of laboratory animals for companies. The main activity of the company is to produce genetically engineered mice and rats for research use.

Amount available for acquisitions: $35bn alternative investment (private equity, venture capital, hedge funds, and managed futures) and a sufficient amount of capital available in addition.

The company has a global footprint and ability to use its facilities for the research such as laboratories, breeding facilities and shipping capabilities. 

Contact us to get details about this pre-clinical animal model pharmaceutical company.


Activities and products of the target company 

The buyer wants to acquire a fully- licensed pharmaceutical company or contract research organization that has expertise in genetically engineered rodent models and services - operates as a breeder and supplier of laboratory animals. The company should have experiences with animal solutions so that customers can acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Preferred company would have laboratories, breeding facilities and capabilities to deliver animal models.

Highlights of this pre-clinical animal model pharmaceutical company buyer

  • A US licensed company that operates as a large breeder and supplier of laboratory animals for companies. 
  • Interested in acquiring a fully- licensed pharmaceutical company or contract research organization that has expertise in genetically engineered rodent models and services - operates as a breeder and supplier of laboratory animals.
  • Have experiences with animal solutions so that customers can acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Preferred company would have laboratories, breeding facilities and capabilities to deliver animal models.
  • Conduct ancillary services for animal models and CROs simultaneously with manufacturing and B2B services
  • The target should have the revenue between (5– 50 million eur).

Information on this buyer of pre-clinical animal model pharmaceutical company 

Feel free to contact us for more information regarding this CRO manufacturer buyer wanted in Europe or if you know possible interested or suited parties, please visit the section pharmaceutical company wanted. For pharmaceutical manufacturing firm for sale the section pharmaceutical company for sale.



Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.